Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1956 1
1961 6
1962 5
1963 2
1964 4
1965 4
1966 3
1968 3
1969 8
1970 3
1971 3
1972 2
1973 2
1974 11
1975 8
1976 9
1977 10
1978 18
1979 18
1980 24
1981 32
1982 30
1983 40
1984 28
1985 23
1986 20
1987 34
1988 39
1989 38
1990 47
1991 31
1992 52
1993 48
1994 43
1995 52
1996 52
1997 67
1998 69
1999 74
2000 115
2001 100
2002 159
2003 131
2004 150
2005 143
2006 143
2007 145
2008 152
2009 157
2010 171
2011 221
2012 196
2013 176
2014 178
2015 170
2016 182
2017 192
2018 204
2019 197
2020 205
2021 211
2022 241
2023 213
2024 167
2025 95

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,824 results

Results by year

Filters applied: . Clear all
Page 1
CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.
Sato Y, Oguchi A, Fukushima Y, Masuda K, Toriu N, Taniguchi K, Yoshikawa T, Cui X, Kondo M, Hosoi T, Komidori S, Shimizu Y, Fujita H, Jiang L, Kong Y, Yamanashi T, Seita J, Yamamoto T, Toyokuni S, Hamazaki Y, Hattori M, Yoshikai Y, Boor P, Floege J, Kawamoto H, Murakawa Y, Minato N, Yanagita M. Sato Y, et al. Among authors: yoshikawa t. J Clin Invest. 2022 Jan 18;132(2):e146071. doi: 10.1172/JCI146071. J Clin Invest. 2022. PMID: 34813503 Free PMC article.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. Chen LT, et al. Among authors: yoshikawa t. Gastric Cancer. 2020 May;23(3):510-519. doi: 10.1007/s10120-019-01034-7. Epub 2019 Dec 20. Gastric Cancer. 2020. PMID: 31863227 Free PMC article. Clinical Trial.
Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy and guides targeted cancer treatment.
Shoji H, Hirano H, Nojima Y, Gunji D, Shinkura A, Muraoka S, Abe Y, Narumi R, Nagao C, Aoki M, Obama K, Honda K, Mizuguchi K, Tomonaga T, Saito Y, Yoshikawa T, Kato K, Boku N, Adachi J. Shoji H, et al. Among authors: yoshikawa t. Cell Rep. 2024 Oct 22;43(10):114774. doi: 10.1016/j.celrep.2024.114774. Epub 2024 Oct 1. Cell Rep. 2024. PMID: 39357518 Free article.
Intestinal Dysbiosis and Autoimmune Pancreatitis.
Yoshikawa T, Watanabe T, Kamata K, Hara A, Minaga K, Kudo M. Yoshikawa T, et al. Front Immunol. 2021 Mar 23;12:621532. doi: 10.3389/fimmu.2021.621532. eCollection 2021. Front Immunol. 2021. PMID: 33833754 Free PMC article. Review.
Cancer immunotherapy-targeted glypican-3 or neoantigens.
Shimizu Y, Suzuki T, Yoshikawa T, Tsuchiya N, Sawada Y, Endo I, Nakatsura T. Shimizu Y, et al. Among authors: yoshikawa t. Cancer Sci. 2018 Mar;109(3):531-541. doi: 10.1111/cas.13485. Epub 2018 Feb 14. Cancer Sci. 2018. PMID: 29285841 Free PMC article. Review.
Next-Generation Cancer Immunotherapy Targeting Glypican-3.
Shimizu Y, Suzuki T, Yoshikawa T, Endo I, Nakatsura T. Shimizu Y, et al. Among authors: yoshikawa t. Front Oncol. 2019 Apr 10;9:248. doi: 10.3389/fonc.2019.00248. eCollection 2019. Front Oncol. 2019. PMID: 31024850 Free PMC article. Review.
State-of-the-art MR Imaging for Thoracic Diseases.
Tanaka Y, Ohno Y, Hanamatsu S, Obama Y, Ueda T, Ikeda H, Iwase A, Fukuba T, Hattori H, Murayama K, Yoshikawa T, Takenaka D, Koyama H, Toyama H. Tanaka Y, et al. Among authors: yoshikawa t. Magn Reson Med Sci. 2022 Mar 1;21(1):212-234. doi: 10.2463/mrms.rev.2020-0184. Epub 2021 Apr 29. Magn Reson Med Sci. 2022. PMID: 33952785 Free PMC article. Review.
4,824 results